Zydus Lifesciences Limited (ZYDUSLIFE NSE) stock market data APIs
INR896.4928
-2.23(-0.2%)
as of May 16, 2025
Try our APIs with
free plan!
Zydus Lifesciences Limited Financial Data Overview
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company provides the products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.
Prev. Close
896.4928
Open
894.2606
High
900.4435
Low
906.1097
52 wk Range
795-1324.3
Market Cap
908 631 M
P/E Ratio
20.0422
Shares Outstanding
1 006 M
Revenue
222 474 M
Dividends (Yield)
0.0033
Beta
0.467
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Zydus Lifesciences Limited data using free add-ons & libraries
Get Zydus Lifesciences Limited Fundamental Data
{
"General": {
"Code": "ZYDUSLIFE",
"Type": "Common Stock",
"Name": "Zydus Lifesciences Limited",
"Exchange": "NSE",
"CurrencyCode": "INR",
"CurrencyName": "Indian Rupee",
"CurrencySymbol": "INR",
"CountryName": "India",
"CountryISO": "IN",
"OpenFigi": null,
"ISIN": "INE010B01027",
"CIK": null,
"EmployerIdNumber": null,
"FiscalYearEnd": "March",
"IPODate": null,
"InternationalDomestic": null,
"Sector": "Healthcare",
"Industry": "Drug Manufacturers - Specialty & Generic",
"Description": "Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formula..."
}
}Zydus Lifesciences Limited Fundamental data includes:
- Net Revenue: 222 474 M
- EBITDA: 62 175 M
- Earnings Per Share: 45
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-28
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zydus Lifesciences Limited News
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
